This study will include individuals aged 18-80 years who have been clinically diagnosed with stroke and have spent at least one month at home after discharge. Sociodemographic and clinical characteristics will be recorded. Functional status will be assessed using the Modified Rankin Scale, Brunnstrom Stages, and the Modified Barthel Index. Ambulation status will be documented with the Holden Scale.
The scale will first be translated into Turkish and then back-translated into English by a bilingual expert whose native language is English. The Turkish version of the scale will be administered to patients. Two independent evaluators will apply the scale twice, one week apart.
Validity will be examined by analyzing the relationship between the scale and the Stroke Impact Scale and the Treatment Burden Questionnaire
Clinical diagnosis of stroke (ischemic or hemorrhagic).
Having spent at least 1 month at home after hospital discharge (to capture post-acute home care/rehabilitation burden).
Community-dwelling individuals aged 18-80 years.
Adequate Turkish reading-writing and communication ability.
History of subarachnoid hemorrhage.
Inability to communicate effectively due to severe aphasia or severe cognitive impairment.
Terminal illness (life expectancy < 6 months).
Inability to complete the questionnaire reliably due to a psychiatric disorder.
Clinical diagnosis of stroke (ischemic or hemorrhagic).
Cohort
Cross-sectional
no intervention
Other interventionno intervention
PETS-Stroke scale
The primary measure, the PETS-Stroke scale, evaluates patients' experiences with treatment and self-management; its scoring system is based on subscale scores typically transformed to 0-100, with higher values reflecting greater perceived burden or difficulty in treatment and self-management.
The Modified Rankin Scale
The Modified Rankin Scale will be used to assess overall functional status; this scale measures global disability on a 0-6 range, with higher scores indicating greater dependence.
Modified Barthel Index
Independence in activities of daily living will be assessed with the Modified Barthel Index, scored between 0 and 100, where higher scores reflect greater functional independence.
Stroke Impact Scale
To assess construct validity, the Stroke Impact Scale will be used; it measures the impact of stroke on domains such as daily activities, mobility, hand function, communication, emotion, memory, and participation, with domain scores transformed to a 0-100 scale in which higher scores represent better status.
Treatment Burden Questionnaire
Treatment burden will be evaluated with the Treatment Burden Questionnaire, where items are scored from 0 to 10, and higher scores indicate greater perceived treatment burden.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
